Developmentally regulated responsiveness to transforming growth factor-β is correlated with functional differences between human adult and fetal primitive hematopoietic progenitor cells

Leukemia

Volumn 13, Issue 8, 1999, Pages 1266-1272

  Weekx, S F A ^d   Plum, J ^d   Van Cauwelaert, P ^a   Lenjou, M ^d   Nijs, G ^d   De Smedt, M ^d   Vanhove, M ^a   Muylaert, P ^a   Van Bockstaele, D R ^d   Berneman, Z ^c   Snoeck, H W ^b  

^a MIDDELHEIM HOSPITAL   (Belgium)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^c ANTWERP UNIVERSITY HOSPITAL   (Belgium)

^d NONE

Author keywords

CD34+CD38 cells; Hematopoiesis; Human adult bone marrow; Human fetal liver; TGF

Indexed keywords

CD34 ANTIGEN; CD38 ANTIGEN; CYTOKINE; TRANSFORMING GROWTH FACTOR BETA;

ARTICLE; BONE MARROW; CELL CULTURE; CELL CYCLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CORRELATION FUNCTION; FETUS; FETUS LIVER; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; PRIORITY JOURNAL;

EID: 0032857547     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2401462     Document Type: Article

References (42)

1. Tavassoli M. Embryonic and fetal hematopoiesis: an overview. Blood Cells 1991; 1: 269-281.
2. Huang H, Auerbach R. Identification and characterization of hematopoietic stem cells from the yolk sac of the early mouse embryo. Proc Natl Acad Sci USA 1993; 90: 10110-10114.
3. Migliaccio G, Migliaccio AR, Petti S, Mavilio F, Russo C, Lazzaro D, Testa U, Marinucci M, Peschle C. Human embryonic hemopoiesis. Kinetics of progenitors and precursors underlaying the yolk sac → liver transition. J Clin Invest 1986; 78: 51-60.
4. Godin I, Dieterlen-Lièvre F, Cumano A. Emergence of multipotent hemopoietic cells in the yolk sac and paraaortic splanchnopleura in mouse embryos, beginning at 8.5 days postcoitus. Proc Natl Acad Sci USA 1995; 92: 773-777.
5. + hematopoietic cells in the early human embryo. Blood 1996; 87: 67-72.
6. Wood HB, May G, Healy L, Enver T, Morris-Kay GM. CD34 expression patterns during early mouse development are related to modes of blood vessel formation and reveal additional sites of hematopoiesis. Blood 1997; 90: 2300-2311.
7. Taniguchi H, Toyoshima T, Fukao K, Nakauchi H. Presence of hematopoietic stem cells in the adult liver. Nature Med 1996; 2: 198-203.
8. + stem cells and thymocyte precursors in the livers of adult mice. J Exp Med 1996; 184: 687-693.
9. - progenitor cells. Bood 1991; 77: 1218-1227.
10. + human hematopoietic progenitor cells. J Exp Med 1994; 180: 1177-1182.
11. Civin CI, Almeida-Porada G, Lee MJ, Olweus J, Terstappen LWMM, Zanjani ED. Sustained, retransplantable, multilineage engraftment of highly purified adult human bone marrow stem cells in vivo. Blood 1996; 88: 4102-4109.
12. Bhatia M, Wang JCY, Kapp U, Bonnet D, Dick JE. Purification of primitive human hematopoietic cells capable of repopulating immune-deficient mice. Proc Natl Acad Sci USA 1997; 94: 5320-5325.
13. - cells in cord blood and bone marrow. Blood 1995; 86: 3745-3753.
14. Lansdorp PM, Dragowska W, Mayani H. Ontogeny-related changes in proliferative potential of human hematopoietic cells. J Exp Med 1993; 178: 787-791.
15. + human hematopoietic progenitors from fetal liver, cord blood and adult bone marrow respond differently to hematopoietic cytokines depending on the ontogenic source. Exp Hematol 1998; 26: 1034-1042.
16. Hatzfeld J, Li ML, Brown EL, Sookdeo H, Lévesque JP, O'Tolle T, Gurney C, Clark SC, Hatzfeld A. Release of early human hematopoietic progenitors from quiescence by antisense transforming growth factor β1 or Rb oligonucleotide. J Exp Med 1991; 174: 925-929.
17. - human umbilical cord blood cells reveals their potentiality to engraft adults. Proc Natl Acad Sci USA 1993; 90: 8707-8711.
18. Fortunel N, Batard P, Hatzfeld A, Monier M-N, Panterne B, Lebkowski J, Hatzfeld J. High proliferative potential-quiescent cells: a working model to study primitive quiescent hematopoietic cells. J Cell Sci 1998; 111: 1867-1875.
19. Bühring HJ, Ullrich A, Schaudt K, Müller CA, Busch W. The product of the proto-oncogene c-kit (P145c-kit) is a human bone marrow surface antigen of hematopoietic precursor cells which is expressed on a subset of acute non-lymphoblastic leukemic cells. Leukemia 1991; 5: 854-860.
20. low cells in which anti-TGF-β upmodulates c-kit. Blood 1995; 86: 1729-1735.
21. Hatzfeld A, Batard P, Panterne B, Taieb F, Hatzfeld J. Increased stable retroviral gene transfer in early hematopoietic progenitors released from quiescence. Hum Gene Ther 1996; 7: 207-213.
22. Dubois CM, Ruscetti FW, Palaszynski W, Falk LA, Oppenheim JJ, Keller JR. Transforming growth factor-β is a potent inhibitor of interleukin-1 (IL-1) receptor expression: proposed mechanism of inhibition of IL-1 action. J Exp Med 1990; 172: 737-744.
23. Jacobsen SEW, Ruscetti FW, Roberts AB, Keller JR. TGF-β is a bidirectional modulator of cytokine receptor expression on murine bone marrow cells. J Immunol 1993; 151: 4534-4544.
24. Jacobsen SE, Ruscetti FW, Dubois CM, Lee J, Boone TC, Keller JR. Transforming growth factor-beta transmodulates the expresion of colony-stimulating factor receptors on murine hematopoietic progenitor cell lines. Blood 1991; 77: 1706-1716.
25. Jacobsen SE, Veiby OP, Myklebust J, Okkenhaug C, Lyman SD. Ability of flt3 ligand to stimulate the in vitro growth of primitive murine hematopoietic progenitors is potently and directly inhibited by transforming growth factor-β and tumor necrosis factor-α. Blood 1996; 87: 5016-5026.
26. Dubois CM, Ruscetti FW, Stankova J, Keller JR. Transforming growth factor-β regulates c-kit message stability and cell-surface protein expression in hematopoietic progenitors. Blood 1994; 83: 3138-3145.
27. Ploemacher RE, van Soest PL, Boudewijn A. Autocrine transforming growth factor-beta 1 blocks colony formation and progenitor cells generation by hematopoietic stem cells stimulated with steel factor. Stem Cell (Dayt) 1993; 11: 336-347.
28. + hematopoietic progenitors to cytokines is determined by the balance between synergy of multiple stimulators and negative cooperation of multiple inhibitors. Exp Hematol 1994; 22: 985-989.
29. + human marrow cells that express low levels of kit protein are enriched for long-term marrow-engrafting cells. Blood 1996; 87: 4136-4142.
30. Vaziri H, Dragowska W, Allsopp RC, Thomas TE, Harley CB, Lansdorp PM. Evidence for a mitotic clock in human hematopoietic stem cells: loss of telomeric DNA with age. Proc Natl Acad Sci USA 1994; 91: 9857-9860.
31. Engelhardt M, Kumar R, Albanell J, Pettengell R, Han W, Moore MAS. Telomerase regulation, cell cycle, and telomerase stability in primitive hematopoietic cells. Blood 1997; 90: 182-193.
32. Lansdorp PM. Lessons from mice without telomerase. J Cell Biol 1997; 139: 309-312.
33. Morrison SJ, Prowse KR, Ho P, Weissman IL. Telomerase activity in hematopoietic cells is associated with self-renewal potential. Immunity 1996; 5: 207-216.
34. de Haan C, Nijhof W, Van Zant G. Mouse strain-dependent changes in frequency and proliferation of hematopoietic stem cells during aging: correlation between lifespan and cycling activity. Blood 1997; 89: 1543-1550.
35. Flemming WH, Alpern EJ, Uchida N, Ikuta K, Spangrude GJ, Weissman IL. Functional heterogeneity is associated with the cell cycle status of murine hematopoietic stem cells. J Cell Biol 1993; 122:897-902.
36. Morrison SJ, Wandycz AM, Akashi K, Weissman IL. The aging of hematopoietic stem cells. Nature Med 1996; 2: 1011-1016.
37. Rebel VI, Miller CL, Thornsbury CR, Dragowska WH, Eaves CJ, Lansdorp PM. A comparison of long-term repopulating hematopoietic stem cells in fetal liver and adult bone marrow from the mouse. Exp Hematol 1996; 24: 638-648.
38. Rebel VI, Miller CL, Eaves CJ, Lansdorp PM. The repopulation potential of fetal liver hematopoietic stem cells in mice exceeds that of their adult bone marrow counterparts. Blood 1996; 87: 3500-3507.
39. Van Zant G, de Haan G, Rich IN. Alternatives to stem cell renewal from a developmental viewpoint. Exp Hematol 1997; 25: 187-192.
40. Tang B, Böttinger EP, Jakowlew SB, Bagnall KM, Mariano J, Anver MR, Letterio JJ, Wakefield M. Transforming growth factor-β1 is a new form of tumor suppressor with true haploid insufficiency. Nature Med 1998; 4: 802-807.
41. Hahn SA, Schutte M, Hoque ATMS, Moskaluk CA, da Costa LT, Rozenblum E, Weinstein CL, Fischer A, Yeo CJ, Hruban RH, Kern SE. DPC4, a candidate tumor supressor gene at human chromosome 18q21.1. Science 1996; 271: 350-353.
42. de Winter JP, Roelen BAJ, ten Dijke P, van der Burg B, van den Eijnden-van Raaij AJM. DPC4 (SMAD4) mediates transforming growth factor-β1 (TGF-β1) induced growth inhibition and transcriptional response in breast tumour cells. Oncogene 1997; 14: 1891-1898.